Psoralen photochemotherapy for vitiligo
- 1 November 1997
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 15 (6) , 921-926
- https://doi.org/10.1016/s0738-081x(97)00133-8
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Guidelines of care for vitiligoJournal of the American Academy of Dermatology, 1996
- Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligoArchives of Dermatology, 1995
- Photochemotherapy beyond psoriasisJournal of the American Academy of Dermatology, 1994
- Melanocyte Movement In Vitro: Role of Matrix Proteins and Integrin ReceptorsJournal of Investigative Dermatology, 1993
- Genital Tumors among Men with Psoriasis Exposed to Psoralens and Ultraviolet A Radiation (PUVA) and Ultraviolet B RadiationNew England Journal of Medicine, 1990
- Effect of 8-Methoxypsoralen Plus Long-Wave Ultraviolet (PUVA) Radiation on Mast Cells. II. In Vitro PUVA Inhibits Degranulation of Rat Peritoneal Mast Cells Induced by Compound 48/80Journal of Investigative Dermatology, 1986
- Determination of optimal topical photochemotherapy for vitiligoJournal of the American Academy of Dermatology, 1982
- Sensitivity of mononuclear cells to PUVA: effect on subsequent stimulation with mitogens and on exclusion of trypan blue dyeClinical and Experimental Dermatology, 1981
- INHIBITION OF DELAYED HYPERSENSITIVITY REACTION IN SKIN (DNCB TEST) BY 8-METHOXYPSORALEN PHOTOCHEMOTHERAPYThe Lancet, 1980
- Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light systemArchives of Dermatology, 1976